Nexe Innovation’s (NEXE.V) XOMA Superfoods has launched its XOMA keto micro-ground coffee pods. “Our line of premium superfood coffees are conveniently packaged in our single-serve, fully compostable, plant-based NEXE…
Robertson
Plurilock Security (PLUR.V) has filed two provisional patent applications with the US Patent and Trademark Office to extend its patent portfolio of new advancements in continuous authentications technology. “These…
PharmaCielo (PCLO.V) has completed initial shipments of its active pharmaceutical ingredients (APIs) to two customers in Brazil following the confirmation of the Company’s compliance with Brazilian Good Manufacturing Practices…
InMed Pharmaceutical’s (IN.T) IntegraSyn™ cannabinoid manufacturing approach has achieved a level of 2 grams per liter (g/L), marking a significant milestone for the commercialization of IntegraSyn™. “We are very…
Enthusiast Gaming (EGLX.T) has signed a partnership with ExitLag, a Brazilian software company focused on providing the best online gaming experience for gamers through optimized internet services. “ExitLag’s decision…
Tetra Bio-Pharma (TBP.T) has shipped Qixleef, its investigational new drug, to the United States for initiation of the REBORN1 study. The REBORN1 study will investigate cannabis as an alternative…
Naturally Splendid (NSP.V) has received the third shipping container of Natera plant-based foods from its manufacturer in Australia. “Our Natera offerings are about consumer inclusion, not exclusion. We believe…
Pure Extract’s (PULL.C) wholly owned subsidiary, Pure Extracts Manufacturing, has begun production of 25,000 vape cartridges for the Canadian retail market. “We are excited about preparing to ship our…
Intema Solutions (ITM.V) has signed a Letter of Acceptance (LOA) on April 20, 2021 to acquire all the shares of TheSmack.gg in exchange for $35,000 in cash. “At the…
Aion Therapeutics’ (AION.C) proprietary and patented combinatorial mushroom preparations, Aion F7 and Aion F8, have shown high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and…